0 -0.000280946913248363 -0.000561893826496864 0.000830625656560799 -0.00083062565656066 0.0028583294652237 0.0028583294652237 0.0028583294652237
Sign Up Today X
Thanks for submitting the form.
Stockreport

Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
The company reported earnings of 10 cents per ADR in the year-ago quarter. Core earnings of €0.24 per share deteriorated 36.8% year over year due to impairment losses at the Crop Science division. Total sales in the reported quarter were $10.9 billion (€9.9 billion), down 3.6% on a reported basis. On a currency and portfolio-adjusted basis, sales increased 0.6% year over year. Year to date, shares of Bayer have lost 30.1% against the industry's growth of 11.6%. Image Source: Zacks Investment Research Find the latest EPS estimates and surprises on Zacks Earnings Calendar All growth rates mentioned below are on a year-over-year basis after adjusting for currency and portfolio changes. Bayer reports under three segments, namely Crop Science, Pharmaceuticals and Consumer Health. In the reported quarter, Crop Science sales decreased 3.6% to €4 billion. Within this segment, Herbicides business was down 11.5% due to volume declines for glyphosate-based products. This was ma [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
The company reported earnings of 10 cents per ADR in the year-ago quarter. Core earnings of €0.24 per share deteriorated 36.8% year over year due to impairment losses at the Crop Science division. Total sales in the reported quarter were $10.9 billion (€9.9 billion), down 3.6% on a reported basis. On a currency and portfolio-adjusted basis, sales increased 0.6% year over year. Year to date, shares of Bayer have lost 30.1% against the industry's growth of 11.6%. Image Source: Zacks Investment Research Find the latest EPS estimates and surprises on Zacks Earnings Calendar All growth rates mentioned below are on a year-over-year basis after adjusting for currency and portfolio changes. Bayer reports under three segments, namely Crop Science, Pharmaceuticals and Consumer Health. In the reported quarter, Crop Science sales decreased 3.6% to €4 billion. Within this segment, Herbicides business was down 11.5% due to volume declines for glyphosate-based products. This was ma [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS